Publications

Aster Insights and ORIEN® have published hundreds of papers in dozens of scientific journals.

15+

Years of Data & Insights

100+

Publications

400,000

TCC® Patients

18

ORIEN® Members

Filters

Research Focus

Cancer Type

Data Utilized

ORDER BY

All Publications

    Feasibility and Clinical Utility of Reporting Hereditary Cancer Predisposition Pathogenic Variants Identified in Research Germline Sequencing: A Prospective Interventional Study. Hutchcraft, M., Zhang, S., et al.

    2024

    Genomic Classification and Individualized Prognosis in Multiple Myeloma. Maura, F., Rajanna, A.R., et al.

    2024

    Comparing the rate of immunotherapy treatment change due to toxicity by sex. Chua, K., Kronstedt S, et al.

    2024

    A bioinformatics tool for identifying intratumoral microbes from the ORIEN dataset. Wang C., Ma, A., et al.

    2024

    The T Cell Immunoscore as a Reference for Biomarker Development Utilizing Real-World Data from Patients with Advanced Malignancies Treated with Immune Checkpoint Inhibitors. Eljilany, I.; Saghand, P.G., et al.

    2023

    Metabolic Dysregulation Explains the Diverse Impacts of Obesity in Males and Females with Gastrointestinal Cancers. Spencer R. Rosario, Bowen Dong, et al.

    2023

    Exploiting Convergent Phenotypes to Derive a Pan-cancer Cisplatin Response Gene Expression Signature. Scarborough JA, Eschrich SA, et al.

    2023

    The tumor microbiome as a predictor of outcomes in patients with metastatic melanoma treated with immune checkpoint inhibitors. Caroline E. Wheeler, Samuel S. Coleman IV, et al.

    2023

    Pan-cancer Landscape of Programmed Death Ligand-1 and Programmed Death Ligand-2 Structural Variations. Hoskins EL, Samorodnitsky E, et al.

    2023

    Factors associated with changes in exercise behaviors during the COVID-19 pandemic. Himbert, C., Hathaway, C.A., Daniels, B. et al.

    2022

    Whitepapers

    Chart A Samples line graph, Chart B table data, Chart C Samples bar graph CRC white paperConsensus Molecular Subtype Analyses in Colorectal Cancer Samples

    April 2023
    Authors: David M. McKean, PhD, Daniel Elgort, PhD, Oliver A. Hampton, PhD, MS, Phaedra Agius, PhD

    Read Whitepaper

    Figure 2 3 charts within RCC White Paper chart OS by Risk Group, StagesIndependent confirmation of the prognostic significance of an immune-related signature in clear cell renal cell carcinoma utilizing real world clinicogenomic data

    April 2023
    Authors: Michael Radmacher, PhD, Daniel Elgort, PhD, Oliver A. Hampton, PhD, MS, and Phaedra Agius, PhD

    Read Whitepaper